Regional dissemination of a trimethoprim-resistance gene cassette via a successful transposable element

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Labar, Amy S ^a   Millman, Jennifer S ^a   Ruebush, Ellen ^a   Opintan, Japheth A ^b   Bishar, Rima A ^a   Aboderin, A Oladipo ^c   Newman, Mercy J ^b   Lamikanra, Adebayo ^c   Okeke, Iruka N ^a  

^a HAVERFORD COLLEGE   (United States)

^b UNIVERSITY OF GHANA   (Ghana)

^c OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CIPROFLOXACIN; KANAMYCIN; MERCURY; NALIDIXIC ACID; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

AFRICA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; DFRA7 GENE; ESCHERICHIA COLI; ETHNICITY; FECES ANALYSIS; GENE CASSETTE; GENE SEQUENCE; GHANA; HUMAN; HUMAN EXPERIMENT; INTEGRON; MULTILOCUS SEQUENCE TYPING; NIGERIA; NIGERIAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSPOSON; DRUG EFFECT; GENE VECTOR; GENETICS; MULTIDRUG RESISTANCE;

ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; GENES, BACTERIAL; GENETIC VECTORS; HUMANS; INTEGRONS; NIGERIA; PLASMIDS; TRIMETHOPRIM;

EID: 84861603991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038142     Document Type: Article

References (93)

1. Lamikanra A, Crowe JL, Lijek RS, Odetoyin BW, Wain J, et al. (2011) Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use. BMC Infect Dis 11: 312.
2. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S, (2011) Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 11: 692-701.
3. Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, et al. (2006) Cost-Effectiveness of HIV Treatment in Resource-Poor Settings - The Case of Cote d'Ivoire. N Engl J Med 355: 1141-1153.
4. Ford N, Mills E, Calmy A, (2009) Rationing Antiretroviral Therapy in Africa - Treating Too Few, Too Late. N Engl J Med 360: 1808-1810.
5. Huovinen P, Sundström L, Swedberg G, Sköld O, (1995) Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother 39: 279-289.
6. Cambray G, Guerout AM, Mazel D, (2010) Integrons. Annu Rev Genet 44: 141-166.
7. Nield BS, Holmes AJ, Gillings MR, Recchia GD, Mabbutt BC, et al. (2001) Recovery of new integron classes from environmental DNA. FEMS Microbiol Lett 195: 59-65.
8. Crespo O, Catalano M, Piñeiro S, Matteo M, Leanza A, et al. (2005) Tn7 distribution in Helicobacter pylori: a selective paradox. International J Antimicrob Agents 25: 341-344.
9. Jansson C, Skold O, (1991) Appearance of a new trimethoprim resistance gene, dhfrIX, in Escherichia coli from swine. Antimicrob Agents Chemother 35: 1891-1899.
10. Jansson C, Franklin A, Skold O, (1992) Spread of a newly found trimethoprim resistance gene, dhfrIX, among porcine isolates and human pathogens. Antimicrob Agents Chemother 36: 2704-2708.
11. Heikkila E, Sundstrom L, Skurnik M, Huovinen P, (1991) Analysis of genetic localization of the type I trimethoprim resistance gene from Escherichia coli isolated in Finland. Antimicrob Agents Chemother 35: 1562-1569.
12. Kraft CA, Timbury MC, Platt DJ, (1986) Distribution and genetic location of Tn7 in trimethoprim-resistant Escherichia coli. J Med Microbiol 22: 125-131.
13. Steen R, Skold O, (1985) Plasmid-borne or chromosomally mediated resistance by Tn7 is the most common response to ubiquitous use of trimethoprim. Antimicrob Agents Chemother 27: 933-937.
14. Ahmed AM, Kawaguchi F, Shimamoto T, (2006) Class 2 integrons in Vibrio cholerae. J Med Microbiol 55: 643-644.
15. Opintan JA, Newman MJ, Nsiah-Poodoh OA, Okeke IN, (2008) Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element. J Antimicrob Chemother 62: 929-933.
16. Brolund A, Sundqvist M, Kahlmeter G, Grape M, (2010) Molecular characterisation of trimethoprim resistance in Escherichia coli and Klebsiella pneumoniae during a two year intervention on trimethoprim use. PLoS ONE 5: e9233.
17. Ajiboye RM, Solberg OD, Lee BM, Raphael E, Debroy C, et al. (2009) Global spread of mobile antimicrobial drug resistance determinants in human and animal Escherichia coli and Salmonella strains causing community-acquired infections. Clin Infect Dis 49: 365-371.
18. Towner KJ, Brennan A, Zhang Y, Holtham CA, Brough JL, et al. (1994) Genetic structures associated with spread of the type Ia trimethoprim- resistant dihydrofolate reductase gene amongst Escherichia coli strains isolated in the Nottingham area of the United Kingdom. J Antimicrob Chemother 33: 25-32.
19. Newman MJ, Seidu A, (2002) Carriage of antimicrobial resistant Escherichia coli in adult intestinal flora. West Afr J Med 21: 48-50.
20. Namboodiri SS, Opintan JA, Lijek RS, Newman MJ, Okeke IN, (2011) Quinolone resistance in Escherichia coli from Accra, Ghana. BMC Microbiol 11: 44.
21. Okeke I, Lamikanra A, Czeczulin J, Dubovsky F, Kaper J, et al. (2000) Heterogeneous virulence of enteroaggregative Escherchia coli strains isolated from children in Southwest Nigeria. Journal of Infectious Diseases 181: 252-260.
22. Okeke IN, Steinruck H, Kanack KJ, Elliott SJ, Sundstrom L, et al. (2002) Antibiotic-resistant cell-detaching Escherichia coli strains from Nigerian children. J Clin Microbiol 40: 301-305.
23. Ashley EA, Lubell Y, White NJ, Turner P, (2011) Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries. Trop Med Int Health 16: 1167-1179.
24. Johnson JR, Menard ME, Lauderdale TL, Kosmidis C, Gordon D, et al. (2011) Global Distribution and Epidemiologic Associations of Escherichia coli Clonal Group A, 1998-2007. Emerg Infect Dis 17: 2001-2009.
25. Okeke IN, Fayinka ST, Lamikanra A, (2000) Antibiotic resistance in Escherichia coli from Nigerian students, 1986 1998. Emerg Infect Dis 6: 393-396.
26. NCCLS, (2003) Performance standards for antimicrobial disk susceptibility tests, 8th Edition; Approved standard. Villanova, PA: National Committee for Clinical Laboratory Standards. NCCLS Document M2-A8 NCCLS Document M2-A8: 130.
27. O'Brien TF, Stelling JM, (1995) WHONET: an information system for monitoring antimicrobial resistance. Emerg Infect Dis 1: 66.
28. Kado CI, Liu ST, (1981) Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 145: 1365-1373.
29. Nwaneshiudu AI, Mucci T, Pickard DJ, Okeke IN, (2007) A second large plasmid encodes conjugative transfer and antimicrobial resistance in O119:H2 and some typical O111 enteropathogenic Escherichia coli strains. J Bacteriol 189: 6074-6079.
30. Sambrook J, Russell DW, (2001) Molecular cloning: a laboratory manual. In: Harbor ColdSpring, editors. N.Y.: Cold Spring Harbor Laboratory Press.
31. Lévesque C, Piché L, Larose C, Roy PH, (1995) PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39: 185-191.
32. White PA, McIver CJ, Rawlinson WD, (2001) Integrons and gene cassettes in the enterobacteriaceae. Antimicrob Agents Chemother 45: 2658-2661.
33. Johnson TJ, Wannemuehler YM, Johnson SJ, Logue CM, White DG, et al. (2007) Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. Appl Environ Microbiol 73: 1976-1983.
34. Tobe T, Hayashi T, Han C, Schoolnik G, Ohtsubo E, et al. (1999) Complete DNA sequence and structural analysis of the enteropathogenic Escherichia coli adherence factor plasmid. Infection and Immunity 67: 5455-5462.
35. Brinkley C, Burland V, Keller R, Rose DJ, Boutin AT, et al. (2006) Nucleotide sequence analysis of the enteropathogenic Escherichia coli adherence factor plasmid pMAR7. Infect Immun 74: 5408-5413.
36. Parkhill J, Dougan G, James KD, Thomson NR, Pickard D, et al. (2001) Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413: 848-852.
37. Lu J, Manchak J, Klimke W, Davidson C, Firth N, et al. (2002) Analysis and characterization of the IncFV plasmid pED208 transfer region. Plasmid 48: 24-37.
38. Fields P, Blom K, Hughes H, Helsel L, Feng P, et al. (1997) Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM. J Clin Microbiol 35: 1066-1070.
39. Wirth T, Falush D, Lan R, Colles F, Mensa P, et al. (2006) Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60: 1136-1151.
40. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, et al. (2000) Artemis: sequence visualization and annotation. Bioinformatics 16: 944-945.
41. Carver T, Thomson N, Bleasby A, Berriman M, Parkhill J, (2009) DNAPlotter: circular and linear interactive genome visualization. Bioinformatics 25: 119-120.
42. Eckert C, Gautier V, Arlet G, (2006) DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother 57: 14-23.
43. Heikkila E, Siitonen A, Jahkola M, Fling M, Sundstrom L, et al. (1990) Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis 161: 1242-1248.
44. Tait S, Amyes SG, (1994) Trimethoprim resistant dihydrofolate reductases in normal faecal flora isolated in India. Epidemiol Infect 113: 247-258.
45. Heikkila E, Sundstrom L, Huovinen P, (1990) Trimethoprim resistance in Escherichia coli isolates from a geriatric unit. Antimicrob Agents Chemother 34: 2013-2015.
46. Vinue L, Saenz Y, Somalo S, Escudero E, Moreno MA, et al. (2008) Prevalence and diversity of integrons and associated resistance genes in faecal Escherichia coli isolates of healthy humans in Spain. J Antimicrob Chemother 62: 934-937.
47. Pallecchi L, Lucchetti C, Bartoloni A, Bartalesi F, Mantella A, et al. (2007) Population structure and resistance genes in antibiotic-resistant bacteria from a remote community with minimal antibiotic exposure. Antimicrob Agents Chemother 51: 1179-1184.
48. Sundström L, Swedberg G, Sköld O, (1993) Characterization of transposon Tn5086, carrying the site-specifically inserted gene dhfrVII mediating trimethoprim resistance. J Bacteriol 175: 1796-1805.
49. Heikkila E, Renkonen OV, Sunila R, Uurasmaa P, Huovinen P, (1990) The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland. J Antimicrob Chemother 25: 275-283.
50. Lee JC, Oh JY, Cho JW, Park JC, Kim JM, et al. (2001) The prevalence of trimethoprim-resistance-conferring dihydrofolate reductase genes in urinary isolates of Escherichia coli in Korea. J Antimicrob Chemother 47: 599-604.
51. Yang CM, Lin MF, Lin CH, Huang YT, Hsu CT, et al. (2009) Characterization of antimicrobial resistance patterns and integrons in human fecal Escherichia coli in Taiwan. Jpn J Infect Dis 62: 177-181.
52. Vasilakopoulou A, Psichogiou M, Tzouvelekis L, Tassios PT, Kosmidis C, et al. (2009) Prevalence and characterization of class 1 integrons in Escherichia coli of poultry and human origin. Foodborne Pathog Dis 6: 1211-1218.
53. El-Najjar NG, Farah MJ, Hashwa FA, Tokajian ST, (2010) Antibiotic resistance patterns and sequencing of class I integron from uropathogenic Escherichia coli in Lebanon. Lett Appl Microbiol 51: 456-461.
54. Bailey JK, Pinyon JL, Anantham S, Hall RM, (2010) Commensal Escherichia coli of healthy humans: a reservoir for antibiotic-resistance determinants. J Med Microbiol 59: 1331-1339.
55. Wain J, Diem Nga LT, Kidgell C, James K, Fortune S, et al. (2003) Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 47: 2732-2739.
56. Ploy MC, Chainier D, Tran Thi NH, Poilane I, Cruaud P, et al. (2003) Integron-associated antibiotic resistance in Salmonella enterica serovar typhi from Asia. Antimicrob Agents Chemother 47: 1427-1429.
57. Lamikanra A, Ako-nai AK, Ogunniyi DA, (1996) Transferable antibiotic resistance in Escherichia coli isolated from healthy Nigerian school children. Int J Antimicrob Agents 7: 59-64.
58. Gassama A, Aidara-Kane A, Chainier D, Denis F, Ploy MC, (2004) Integron-associated antibiotic resistance in enteroaggregative and enteroinvasive Escherichia coli. Microb Drug Resist 10: 27-30.
59. Adrian PV, Klugman KP, Amyes SG, (1995) Prevalence of trimethoprim resistant dihydrofolate reductase genes identified with oligonucleotide probes in plasmids from isolates of commensal faecal flora. J Antimicrob Chemother 35: 497-508.
60. Frank T, Gautier V, Talarmin A, Bercion R, Arlet G, (2007) Characterization of sulphonamide resistance genes and class 1 integron gene cassettes in Enterobacteriaceae, Central African Republic (CAR). J Antimicrob Chemother 59: 742-745.
61. Dahmen S, Mansour W, Boujaafar N, Arlet G, Bouallegue O, (2010) Distribution of cotrimoxazole resistance genes associated with class 1 integrons in clinical isolates of Enterobacteriaceae in a university hospital in Tunisia. Microb Drug Resist 16: 43-47.
62. Chah KF, Agbo IC, Eze DC, Somalo S, Estepa V, et al. (2010) Antimicrobial resistance, integrons and plasmid replicon typing in multiresistant clinical Escherichia coli strains from Enugu State, Nigeria. J Basic Microbiol 50: S18-S24.
63. Ojo KK, Waturangi DE, Odelola HA, Suwanto A, Schwarz S, (2002) Identification of a cassette-borne dfrA7-like gene that shows a 97 bp extension at the 3'-end of the reading frame. J Antimicrob Chemother 49: 573-574.
64. Djie-Maletz A, Reither K, Danour S, Anyidoho L, Saad E, et al. (2008) High rate of resistance to locally used antibiotics among enteric bacteria from children in Northern Ghana. J Antimicrob Chemother 61: 1315-1318.
65. Ceccarelli D, Bani S, Cappuccinelli P, Colombo MM, (2006) Prevalence of aadA1 and dfrA15 class 1 integron cassettes and SXT circulation in Vibrio cholerae O1 isolates from Africa. J Antimicrobl Chemother 58: 1095-1097.
66. Ceccarelli D, Salvia AM, Sami J, Cappuccinelli P, Colombo MM, (2006) New cluster of plasmid-located class 1 integrons in Vibrio cholerae O1 and a dfrA15 cassette-containing integron in Vibrio parahaemolyticus isolated in Angola. Antimicrob Agents Chemother 50: 2493-2499.
67. Solberg OD, Ajiboye RM, Riley LW, (2006) Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic Escherichia coli. J Clin Microbiol 44: 1347-1351.
68. Johnson JR, Manges AR, O'Bryan TT, Riley LW, (2002) A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 359: 2249-2251.
69. France AM, Kugeler KM, Freeman A, Zalewski CA, Blahna M, et al. (2005) Clonal groups and the spread of resistance to trimethoprim-sulfamethoxazole in uropathogenic Escherichia coli. Clin Infect Dis 40: 1101-1107.
70. Holt K, Phan M, Baker S, Duy P, Nga T, et al. (2011) Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid. PLoS Negl Trop Dis 5: e1245.
71. Carattoli A, (2009) Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 53: 2227-2238.
72. Lu S, Zhang X, Zhu Y, Kim KS, Yang J, et al. (2011) Complete Genome Sequence of the Neonatal-Meningitis-Associated Escherichia coli Strain CE10. Journal of Bacteriology 193: 7005.
73. Petty NK, Bulgin R, Crepin VF, Cerdeno-Tarraga AM, Schroeder GN, et al. (2010) The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli. J Bacteriol 192: 525-538.
74. Holt KE, Thomson NR, Wain J, Phan MD, Nair S, et al. (2007) Multidrug-resistant Salmonella enterica serovar paratyphi A harbors IncHI1 plasmids similar to those found in serovar typhi. J Bacteriol 189: 4257-4264.
75. Chen CY, Nace GW, Solow B, Fratamico P, (2007) Complete nucleotide sequences of 84.5- and 3.2-kb plasmids in the multi-antibiotic resistant Salmonella enterica serovar Typhimurium U302 strain G8430. Plasmid 57: 29-43.
76. Venturini C, Beatson SA, Djordjevic SP, Walker MJ, (2010) Multiple antibiotic resistance gene recruitment onto the enterohemorrhagic Escherichia coli virulence plasmid. FASEB J 24: 1160-1166.
77. Yau S, Liu X, Djordjevic SP, Hall RM, (2010) RSF1010-Like plasmids in Australian Salmonella enterica serovar Typhimurium and origin of their sul2-strA-strB antibiotic resistance gene cluster. Microbial Drug Resistance 16: 249-252.
78. Kingsley RA, Msefula CL, Thomson NR, Kariuki S, Holt KE, et al. (2009) Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 19: 2279-2287.
79. Liebert CA, Hall RM, Summers AO, (1999) Transposon Tn21, flagship of the floating genome. Microbiol Mol Biol Rev 63: 507-522.
80. Douard G, Praud K, Cloeckaert A, Doublet B, (2010) The Salmonella genomic island 1 is specifically mobilized in trans by the IncA/C multidrug resistance plasmid family. PLoS ONE 5: e15302.
81. Dawes F, Kuzevski A, Bettelheim K, Hornitzky M, Djordjevic S, et al. (2010) Distribution of class 1 Integrons with IS26 mediated deletions in their 3′-conserved segments in Escherichia coli of human and animal origin. PLoS ONE 5: e12754.
82. Okeke IN, Edelman R, (2001) Dissemination of antibiotic-resistant bacteria across geographic borders. Clin Infect Dis 33: 364-369.
83. Roper C, Pearce R, Nair S, Sharp B, Nosten F, et al. (2004) Intercontinental spread of pyrimethamine-resistant malaria. Science 305: 1124.
84. Lamikanra A, Fayinka ST, Olusanya OO, (1989) Transfer of low level trimethoprim resistance in faecal isolates obtained from apparently healthy Nigerian students. FEMS Microbiol Lett 50: 275-278.
85. Skurnik D, Lacheeb S, Bernede C, le Menac'H A, Elbaz S, et al. (2009) Integrons and Antibiotic Resistance in Phylogenetic Group B2 Escherichia coli. Microbial Drug Resistance 15: 173-178.
86. Anglaret X, Chene G, Attia A, Toure S, Lafont S, et al. (1999) Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 353: 1463-1468.
87. UNAIDS, (2001) Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. Afr Health Sci 1: 30-31.
88. Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, et al. (2008) Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg 79: 320-330.
89. Gangoue-Pieboji J, Koulla-Shiro S, Ngassam P, Adiogo D, Ndumbe P, (2006) Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon Afr Health Sci 6: 232-235.
90. Morpeth SC, Thielman NM, Ramadhani HO, Hamilton JD, Ostermann J, et al. (2008) Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania. J Acquir Immune Defic Syndr 47: 585-591.
91. Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, et al. (2008) Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study. Bull World Health Organ 86: 929-938.
92. Womble DD, Rownd RH, (1988) Genetic and physical map of plasmid NR1: comparison with other IncFII antibiotic resistance plasmids. Microbiolog Rev 52: 433-451.
93. Simon U, Priefer R, Pühler A, (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Bio/Technology 1: 784-791.